ARCELLX, INC. STANDSTILL AND STOCK RESTRICTION AGREEMENTStandstill and Stock Restriction Agreement • March 29th, 2023 • Arcellx, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 29th, 2023 Company Industry JurisdictionThis Standstill and Stock Restriction Agreement (this “Agreement”) is made as of December 8, 2022 (“Effective Date”) by and among Arcellx, Inc., a Delaware corporation (the “Company”) and Gilead Sciences, Inc., a Delaware corporation (the “Investor”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 29th, 2023 • Arcellx, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 29th, 2023 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of December 8, 2022 by and among Arcellx, Inc., a Delaware corporation (the “Company”), and Gilead Sciences, Inc., a Delaware corporation (the “Investor”).
COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN ARCELLX, INC. AND KITE PHARMA, INC.Collaboration and License Agreement • March 29th, 2023 • Arcellx, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 29th, 2023 Company Industry Jurisdiction